First Clinical Site Preparation started
The first PERISCOPE clinical study is about to start - on April 27th, 2017, the future team that will be involved in the implementation of the study came together for a site initiation visit at NIHR Wellcome Trust Clinical Research Facility in Southampton, UK.
The study team discussed the trial protocol, the monitoring plan and requirements and was familiarised with the database. Chief investigator Prof Rob Read will lead the study called “Pertussis Human Challenge Colonisation Study” – a human controlled infection study to establish a safe, reproducible and practical human Bordetella pertussis colonisation model for the identification of correlates of protection against colonisation.
The study is one of nine clinical studies planned within PERISCOPE.